MARKETS PERPS LIVE79

Cash

Trending Elections Politics Sports Culture Crypto Commodities Climate Economics Mentions Finance Tech & Science

Predict Live79 AccountSocial

Product

Kalshi Pro Perpetual Futures Markets Incentive program Institutions API & developers

Company

About Kalshi Research Blog Careers Policy Center Brand Kit

Help

Help Center FAQ Fee schedule Trading hours Regulatory Trust Center

© 2026 Kalshi Inc. · All rights reserved

Privacy Data Terms of Service Trading Prohibitions FAQ for Finance Professionals

Trading on Kalshi involves risk and may not be appropriate for all. Members risk losing their cost to enter any transaction, including fees. You should carefully consider whether trading on Kalshi is appropriate for you in light of your investment experience and financial resources. Any trading decisions you make are solely your responsibility and at your own risk. Information is provided for convenience only on an "AS IS" basis. Past performance is not necessarily indicative of future results. Kalshi is subject to U.S. regulatory oversight by the CFTC.

Johnson & Johnson

JNJ

ReportsOct 13, 2026 · before open

Fiscal periodNot stated

Market cap$638.00B

Consensus EPS$2.90 · 7 estimates

Year-ago EPS$2.80

Expected change+3.6%

Quarterly markets

What will Johnson & Johnson say during their next earnings call?

China
94%
Procedure
94%
Tecvayli
94%
Ottava
94%
Rybrevant
93%
Firefly Bio
93%
Caplyta
89%
Tariff
83%
Litigation
76%
Darzalex Faspro
69%
Halda Therapeutics
55%
AI / Artificial Intelligence
46%

4 more words trade on this call

Johnson & Johnson (JNJ) earnings | Kalshi